Currently there is no effective medical treatment for both neurofibroma and MPNST, although recent animal studies have suggested that MEK/ERK pathway could be a target for NF1-associated neoplasms, including plexiform neurofibroma but not MPNST [5–7]. This evidence concerns the gene MAP2K7 and plexiform neurofibroma.